Task: Answer the multiple-choice question.
Question: Which drug exhibits a -4.725% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCn1c(=O)c2c3c(sc2n2cnnc12)CCC3
b.) CCN(CC)S(=O)(=O)c1ccc(Cl)c(C(=O)Oc2cccc(-c3cnc4ccccc4n3)c2)c1
c.) CC1CCCN(CCCNC(=O)C2CCCN(c3ncnc4c3nc3n4CCCCC3)C2)C1
Answer: c. CC1CCCN(CCCNC(=O)C2CCCN(c3ncnc4c3nc3n4CCCCC3)C2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCCN(CCCNC(=O)C2CCCN(c3ncnc4c3nc3n4CCCCC3)C2)C1
CC1CCCN(CCCNC(=O)C2CCCN(c3ncnc4c3nc3n4CCCCC3)C2)C1
N-[3-(3-methylpiperidin-1-yl)propyl]-1-(7,8,9,10-tetrahydro-6H-purino[9,8-a]azepin-4-yl)piperidine-3-carboxamide